118 related articles for article (PubMed ID: 1845361)
1. Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study.
Houssiau FA; D'Cruz DP; Haga HJ; Hughes GR
Lupus; 1991 Nov; 1(1):31-5. PubMed ID: 1845361
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
6. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
7. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
[TBL] [Abstract][Full Text] [Related]
8. Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy.
Chiu SJ; Ou LS; Tsai TL; Hung IJ; Huang JL
Clin Rheumatol; 2006 Jul; 25(4):515-9. PubMed ID: 16283418
[TBL] [Abstract][Full Text] [Related]
9. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
Chan TM; Tse KC; Tang CS; Lai KN; Li FK
Lupus; 2005; 14(4):265-72. PubMed ID: 15864912
[TBL] [Abstract][Full Text] [Related]
11. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
[TBL] [Abstract][Full Text] [Related]
12. [Appraisal of renal failure reversing therapies in lupus nephritis].
Yang X; Liang L; Zhan Z; Ye Y; Liu Y; Yu X; Chen W; Yin P
Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):113-6. PubMed ID: 11798566
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
14. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis.
Yan DC; Chou CC; Tsai MJ; Chiang BL; Tsau YK; Hsieh KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):203-9. PubMed ID: 7618472
[TBL] [Abstract][Full Text] [Related]
15. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
[TBL] [Abstract][Full Text] [Related]
18. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Cauli A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Ann Rheum Dis; 2010 Jan; 69(1):61-4. PubMed ID: 19155235
[TBL] [Abstract][Full Text] [Related]
19. Intermittent intravenous treatment of lupus nephritis with cyclophosphamide: a four-year experience with twenty-four patients.
Chu SJ; Chang DM; Kuo SY; Hsu CM; Chen CM; Chang ML
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):325-30. PubMed ID: 8087706
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
Mok CC; Ho CT; Siu YP; Chan KW; Kwan TH; Lau CS; Wong RW; Au TC
Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
